AlphAIAlphAI — Financial news for AI agents
investing.comOCT 282 min read$ALGN

Align Technology stock sheds 5% on weak Q4 revenue outlook

Align Technology (ALGN) reported Q3 2026 earnings beating estimates with $2.80 EPS and $1.02B revenue, but shares fell 5% due to Q4 guidance below expectations. Q4 revenue forecasted at $1.00-$1.02B vs. $1.05B consensus. Full-year revenue expected at $4.11-$4.13B vs. $4.15B estimate. Clear Aligner revenues rose 4.2% YoY, while Imaging Systems revenues declined 7.6% YoY.

Original reporting
investing.com
Published Oct 28, 2026, 8:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$ALGN
Bearish
high confidence
Mentioned
$ALGN
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ALGNBearishHigh
01

Why it matters

The guidance shortfall is the primary catalyst for the price move; margin expansion and share buyback provide some upside potential.

02

Market read

First report of earnings and guidance for a large‑cap healthcare equipment company; material for traders.

03

What to watch

Strong Clear Aligner volume growth and improved margins may offset guidance concerns.

Relevance 8/10Novelty 8/10Timing: after‑hours today

Background

Align Technology reported Q3 FY2026 results that beat EPS and revenue estimates, but issued Q4 guidance below consensus, prompting a 5% after‑hours decline.

Company-level read

Ticker impact

$ALGNBearishHigh confidence
Context

Shares fell 5% after hours as Q4 revenue guidance of $1.00‑$1.02B missed consensus of $1.05B.

Expected impact

downward pressure as investors price in lower revenue outlook

Evidence & confidence

Guidance shortfall is material for a large‑cap dental device maker and triggered an immediate 5% drop.

Market effects

Sector

Dental and orthodontic equipment sector may see broader pressure on peers.

Regional

U.S. equity markets could see modest downside in healthcare equipment stocks.

Global

Limited to markets tracking Align Technology and related suppliers.

Counterpoint

What could challenge this read

The $300 M share‑repurchase program could support the price if executed aggressively.

Key entities

  • company
    Align Technology, Inc.

    Dental device maker that reported Q3 results and issued Q4 guidance.

Read at source← All news

StoryAlign Technology posts Q3 beat but shares slide on weaker Q4 outlook

Also covered by

3 outlets

Related articles

OCT 28
$ALGNLow

Procter & Gamble's former global healthcare CEO will lead Align on Dec. 31.

Align Technology (ALGN) has appointed Jennifer L. Davis, former CEO of Procter & Gamble’s Global Healthcare, as its new President and CEO effective December 31, 2026. Davis brings 33 years of experience in healthcare and consumer brands. Current CEO Joseph M. Hogan will step down but support the transition. The company also released its third-quarter 2026 financial results and will host a conference call.

stocktitan.net2 min
OCT 28
$ALGNHighAI 8/10

Clear-aligner shipments rose 6.6% to 690,635 cases at Align Technology.

Align Technology reported Q3 2026 revenues of $1.015 billion, up 1.9% YoY. Clear Aligner revenues rose 4.2% YoY to $839.3 million, with shipments up 6.6% to 690,635 cases. Imaging Systems and CAD/CAM Services revenues fell 7.6% YoY. Gross margin was 68.7% (70.4% non-GAAP), and operating margin improved to 16.7% (24.4% non-GAAP). The company repurchased 627.3K shares and expects Q4 revenues between $1.020B and $1.000B.

stocktitan.net3 min